Noom Med with SmartRx, in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit ...

Leveraging Waltz Connect by Waltz Health, the two industry leaders together are engineering a joint solution that will provide an end-to-end program that helps employees more seamlessly access and ...

Noom is rolling out two new solutions that aim to make it easier for employers and members to manage GLP-1s, and it's teaming ...

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and ...

Noom says the new scanning technology developed in partnership with Prism Labs will provide “actionable health insights”.

The psychology-based digital health care platform Noom announced an AI-powered feature on Thursday that aims to address one ...

Recognizing women's unique health needs, Noom's Women’s Health features include content, tools, and a coach-led community ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Buying cheap knockoffs ofEli Lilly’s and Novo Nordisk’s blockbuster GLP-1 weight-loss drugs has become almost as easy as ordering a new iPhone.

The weight loss company Noom hired McDermott+, formerly McDermott+Consulting, to lobby on issues related to virtual care. Rachel Stauffer, former health policy director for Rep. Diana DeGette (D ...

Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...